KRTAP10-3
geneOn this page
Also known as KAP10.3KAP18.3
Summary
KRTAP10-3 (keratin associated protein 10-3, HGNC:22968) is a protein-coding gene on chromosome 21q22.3, encoding Keratin-associated protein 10-3 (P60369). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
This gene encodes a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This gene encodes a member of the high sulfur KAP family. It is localized to a cluster of intronless KAPs at 21q22.3 which are located within the introns of the C21orf29 gene.
Source: NCBI Gene 386682 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_198696
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22968 |
| Approved symbol | KRTAP10-3 |
| Name | keratin associated protein 10-3 |
| Location | 21q22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP10.3, KAP18.3 |
| Ensembl gene | ENSG00000212935 |
| Ensembl biotype | protein_coding |
| Entrez | 386682 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000391620
RefSeq mRNA: 1 — MANE Select: NM_198696
NM_198696
CCDS: CCDS42956
Canonical transcript exons
ENST00000391620 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001509398 | 44557790 | 44558795 |
Expression profiles
Bgee: expression breadth broad, 13 present calls, max score 42.15.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0171 / max 17.0431, expressed in 2 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190755 | 0.0171 | 2 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 42.15 | gold quality |
| skin of abdomen | UBERON:0001416 | 38.28 | gold quality |
| bone marrow cell | CL:0002092 | 38.27 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| zone of skin | UBERON:0000014 | 36.89 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skin of leg | UBERON:0001511 | 36.18 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.82 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| right lung | UBERON:0002167 | 31.30 | silver quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| right uterine tube | UBERON:0001302 | 29.90 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.39 | gold quality |
| tonsil | UBERON:0002372 | 28.77 | gold quality |
| monocyte | CL:0000576 | 28.46 | gold quality |
| leukocyte | CL:0000738 | 28.39 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| muscle of leg | UBERON:0001383 | 27.76 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| gastrocnemius | UBERON:0001388 | 27.18 | gold quality |
| urinary bladder | UBERON:0001255 | 26.98 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| kidney | UBERON:0002113 | 25.29 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.49 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 10-3 — P60369 (reviewed: P60369)
Alternative names: High sulfur keratin-associated protein 10.3, Keratin-associated protein 10.3, Keratin-associated protein 18-3, Keratin-associated protein 18.3
All UniProt accessions (1): P60369
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Restricted to a narrow region of the hair fiber cuticle, lying approximately 20 cell layers above the apex of the dermal papilla of the hair root; not detected in any other tissues.
Similarity. Belongs to the KRTAP type 10 family.
RefSeq proteins (1): NP_941969* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
Pfam: PF13885
UniProt features (25 total): repeat 18, sequence conflict 3, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P60369-F1 | 39.11 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 12 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, BPTF_TARGET_GENES, ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE, TATAAA_TATA_01, CTGCAGY_UNKNOWN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
168 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP10-3 | OR1E1 | P30953 | 525 |
| KRTAP10-3 | KRTAP2-3 | P0C7H8 | 474 |
| KRTAP10-3 | KRT38 | O76015 | 449 |
| KRTAP10-3 | MUCL3 | Q3MIW9 | 447 |
| KRTAP10-3 | PRB3 | Q04118 | 432 |
| KRTAP10-3 | IGFL1 | Q6UW32 | 419 |
| KRTAP10-3 | PERM1 | Q5SV97 | 418 |
| KRTAP10-3 | KRT26 | Q7Z3Y9 | 417 |
| KRTAP10-3 | KRTAP1-1 | Q07627 | 397 |
| KRTAP10-3 | RP1L1 | Q8IWN7 | 355 |
| KRTAP10-3 | AGR3 | Q8TD06 | 348 |
| KRTAP10-3 | SAGE1 | Q9NXZ1 | 348 |
| KRTAP10-3 | FBN3 | Q75N90 | 336 |
| KRTAP10-3 | A0A087WZY1 | A0A087WZY1 | 336 |
| KRTAP10-3 | PRH1 | P02810 | 322 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-3 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | ACY3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | WT1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | LCE1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | CHRNG | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | ZNF786 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | ZNF559 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRTAP10-3 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | KRTAP10-3 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (304): KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-3 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: P60014, P60331, P60368, P60369, P60370, P60371, P60409, P60411, P60412, P60413, P60372, A6QP35, P60410
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 12 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
437 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:44558023:CAACT:C | acceptor_gain | 0.8600 |
| 21:44558567:A:AC | donor_gain | 0.8600 |
| 21:44558568:C:CC | donor_gain | 0.8600 |
| 21:44558664:G:A | donor_gain | 0.8600 |
| 21:44558658:C:CT | donor_gain | 0.8100 |
| 21:44558636:CAG:C | donor_gain | 0.7900 |
| 21:44558659:C:CT | donor_gain | 0.7900 |
| 21:44558026:CT:C | acceptor_gain | 0.7800 |
| 21:44558657:TCC:T | donor_gain | 0.7800 |
| 21:44558025:ACTCT:A | acceptor_gain | 0.7600 |
| 21:44558026:CTCTG:C | acceptor_gain | 0.7400 |
| 21:44558024:AACTC:A | acceptor_gain | 0.7300 |
| 21:44558635:A:AC | donor_gain | 0.7200 |
| 21:44558636:C:CC | donor_gain | 0.7200 |
| 21:44558024:AACT:A | acceptor_gain | 0.6900 |
| 21:44558028:C:G | acceptor_gain | 0.6800 |
| 21:44558028:C:CC | acceptor_gain | 0.6700 |
| 21:44558656:GTC:G | donor_gain | 0.6600 |
| 21:44557981:CAGGG:C | acceptor_gain | 0.6400 |
| 21:44558560:ACAG:A | donor_gain | 0.6400 |
| 21:44558561:CAGC:C | donor_gain | 0.6400 |
| 21:44558563:G:GA | donor_gain | 0.6300 |
| 21:44558578:G:T | donor_gain | 0.6300 |
| 21:44558562:AG:A | donor_gain | 0.6200 |
| 21:44558563:G:C | donor_gain | 0.6200 |
| 21:44557854:C:CT | donor_gain | 0.6100 |
| 21:44557855:C:CT | donor_gain | 0.6100 |
| 21:44557952:C:CC | acceptor_gain | 0.6100 |
| 21:44558027:TC:T | acceptor_loss | 0.6100 |
| 21:44558655:CGT:C | donor_gain | 0.6100 |
AlphaMissense
1421 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1005911315 (21:44560632 C>G), RS1006899016 (21:44560741 G>A,C), RS1009900643 (21:44559651 A>G), RS1011048826 (21:44557652 G>A), RS1013025697 (21:44557331 A>T), RS1013696773 (21:44558740 G>T), RS1014858954 (21:44560361 T>A,C), RS1017813346 (21:44557427 A>C), RS1019539404 (21:44558346 A>T), RS1021962939 (21:44557654 G>A), RS1022457922 (21:44557821 G>A,T), RS1024070716 (21:44559908 T>A,C,G), RS1024412858 (21:44559701 T>A,C), RS1026355091 (21:44557593 C>T), RS1026526724 (21:44557393 G>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:614861, MIM:618180
GenCC curated gene-disease
Mondo (3): autosomal recessive nonsyndromic hearing loss 98 (MONDO:0013929), breast ductal adenocarcinoma (MONDO:0005590), ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis (MONDO:0032584)
Orphanet (2): Rare autosomal recessive non-syndromic sensorineural deafness type DFNB (Orphanet:90636), Hypodontia-scalp hypotrichosis-facial dysmorphism syndrome (Orphanet:685067)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D018270 | Carcinoma, Ductal, Breast | C04.557.470.200.025.232.500; C04.557.470.615.132.500; C04.588.180.390; C17.800.090.500.390 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| MT19c compound | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Pantothenic Acid | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
11 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03414970 | PHASE3 | ACTIVE_NOT_RECRUITING | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer |
| NCT00461344 | PHASE2 | TERMINATED | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer |
| NCT07499999 | PHASE2 | NOT_YET_RECRUITING | Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer |
| NCT00637364 | PHASE1/PHASE2 | SUSPENDED | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain |
| NCT02779855 | PHASE1/PHASE2 | COMPLETED | Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer |
| NCT01753908 | EARLY_PHASE1 | COMPLETED | Broccoli Sprout Extract in Treating Patients With Breast Cancer |
| NCT01796041 | EARLY_PHASE1 | COMPLETED | Intraoperative Imaging of Breast Cancer With Indocyanine Green |
| NCT01208974 | Not specified | ACTIVE_NOT_RECRUITING | Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction |
| NCT01875198 | Not specified | TERMINATED | Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer |
| NCT03543397 | Not specified | UNKNOWN | MRI in Ductal Carcinoma in Situ (DCIS) |
| NCT03834532 | Not specified | COMPLETED | Living Well After Breast Surgery |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autosomal recessive nonsyndromic hearing loss 98, ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis